1. 6 min walk test is a strong independent predictor of death in outpatients with heart failure. (17th July 2020) Authors: Grundtvig, Morten; Eriksen‐Volnes, Torfinn; Ørn, Stein; Slind, Eva Kjøl; Gullestad, Lars Journal: ESC heart failure Issue: Volume 7:Number 5(2020) Page Start: 2904 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A randomized clinical study using optical coherence tomography to evaluate the short‐term effects of high‐intensity interval training on cardiac allograft vasculopathy: a HITTS substudy. Issue 1 (13th December 2021) Authors: Rafique, Muzammil; Solberg, Ole Geir; Gullestad, Lars; Bendz, Bjørn; Holm, Niels Ramsing; Neghabat, Omeed; Dijkstra, Jouke; Nytrøen, Kari; Rolid, Katrine; Lunde, Ketil Journal: Clinical transplantation Issue: Volume 36:Issue 1(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Age-dependent morbidity and mortality outcomes after surgical aortic valve replacement. (9th May 2018) Authors: Hussain, Amjad I; Auensen, Andreas; Brunborg, Cathrine; Beitnes, Jan Otto; Gullestad, Lars; Pettersen, Kjell I Journal: Interactive cardiovascular and thoracic surgery Issue: Volume 27:Number 5(2018) Page Start: 650 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Blood Milieu in Acute Myocardial Infarction Reprograms Human Macrophages for Trauma Repair. Issue 5 (16th December 2022) Authors: Fontaine, Margaux A. C.; Jin, Han; Gagliardi, Mick; Rousch, Mat; Wijnands, Erwin; Stoll, Monika; Li, Xiaofei; Schurgers, Leon; Reutelingsperger, Chris; Schalkwijk, Casper; van den Akker, Nynke M. S.; Molin, Daniel G.M.; Gullestad, Lars; Eritsland, Jan; Hoffman, Pavel; Skjelland, Mona; Andersen, G... Journal: Advanced science Issue: Volume 10:Issue 5(2023) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Blood Pressure in De Novo Heart Transplant Recipients Treated With Everolimus Compared With a Cyclosporine-based Regimen: Results From the Randomized SCHEDULE Trial. Issue 4 (April 2019) Authors: Andreassen, Arne K.; Broch, Kaspar; Eiskjær, Hans; Karason, Kristjan; Gude, Einar; Mølbak, Dorte; Stueflotten, Wenche; Gullestad, Lars Journal: Transplantation Issue: Volume 103:Issue 4(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. CCL21 is associated with fatal outcomes in chronic heart failure: data from CORONA and GISSI‐HF trials. (July 2013) Authors: Ueland, Thor; Nymo, Ståle H.; Latini, Roberto; McMurray, John J.V.; Kjekshus, John; Yndestad, Arne; Fucili, Alessandro; Grosu, Aurelia; Masson, Serge; Maggioni, Aldo P.; Gullestad, Lars; Aukrust, Pål Journal: European journal of heart failure Issue: Volume 15:Number 7(2013) Page Start: 747 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Cholesterol lowering with EVOLocumab to prevent cardiac allograft Vasculopathy in De‐novo heart transplant recipients: Design of the randomized controlled EVOLVD trial. Issue 9 (6th August 2020) Authors: Broch, Kaspar; Gude, Einar; Karason, Kristjan; Dellgren, Göran; Rådegran, Göran; Gjesdal, Grunde; Gustafsson, Finn; Eiskjær, Hans; Lommi, Jyri; Pentikäinen, Markku; Lemström, Karl B.; Andreassen, Arne K.; Gullestad, Lars Journal: Clinical transplantation Issue: Volume 34:Issue 9(2020) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Circulating delta‐like Notch ligand 1 is correlated with cardiac allograft vasculopathy and suppressed in heart transplant recipients on everolimus‐based immunosuppression. Issue 4 (5th November 2018) Authors: Norum, Hilde M.; Michelsen, Annika E.; Lekva, Tove; Arora, Satish; Otterdal, Kari; Olsen, Maria Belland; Kong, Xiang Yi; Gude, Einar; Andreassen, Arne K.; Solbu, Dag; Karason, Kristjan; Dellgren, Göran; Gullestad, Lars; Aukrust, Pål; Ueland, Thor Journal: American journal of transplantation Issue: Volume 19:Issue 4(2019) Page Start: 1050 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Circulating levels and prognostic cut‐offs of sST2, hs‐cTnT, and NT‐proBNP in women vs. men with chronic heart failure. (5th May 2022) Authors: Vergaro, Giuseppe; Gentile, Francesco; Aimo, Alberto; Januzzi, James L.; Richards, A. Mark; Lam, Carolyn S.P.; de Boer, Rudolf A.; Meems, Laura M.G.; Latini, Roberto; Staszewsky, Lidia; Anand, Inder S.; Cohn, Jay N.; Ueland, Thor; Gullestad, Lars; Aukrust, Pål; Brunner‐La Rocca, Hans‐Peter; Bayes... Journal: ESC heart failure Issue: Volume 9:Number 4(2022) Page Start: 2084 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Circulating levels and prognostic value of soluble ST2 in heart failure are less influenced by age than N‐terminal pro‐B‐type natriuretic peptide and high‐sensitivity troponin T. (9th January 2020) Authors: Aimo, Alberto; Januzzi, James L.; Vergaro, Giuseppe; Richards, A. Mark; Lam, Carolyn S.P.; Latini, Roberto; Anand, Inder S.; Cohn, Jay N.; Ueland, Thor; Gullestad, Lars; Aukrust, Pål; Brunner‐La Rocca, Hans‐Peter; Bayes‐Genis, Antoni; Lupón, Josep; de Boer, Rudolf A.; Takeishi, Yasuchika; Egstrup... Journal: European journal of heart failure Issue: Volume 22:Number 11(2020) Page Start: 2078 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗